Over the past several years, people with a degenerative eye disease could recover some vision through a high-tech prosthetic system. Patients went from complete darkness to seeing crude outlines of objects and people. Now Second Sight, the company behind that bionic eye, is developing neurotechnology that promises to do the same for millions worldwide who are blind from other causes.
Recently the company announced they had completed a successful proof of concept study at UCLA. A team there sent wireless signals to the brain of a blind patient through a simple device, which produced spots of light for her.
"It told us that yes, you can stimulate the visual cortex, you can produce a spot of light, and the patient can see that spot and localize it," Second Sight president and CEO Will McGuire told Seeker. Those results are informing the creation of a new product for artificial vision called Orion I that the company hopes to begin testing next year.
Learn more about Second Sight's Orion I project via Seeker.
A New View is a weekly e-blast from Christian Record Services, Inc. A New View is a great way to promote healthy vision choices and share eye health information with your church, family, and friends. To learn more about the outreach of Christian Record Services, Inc. to people who are blind, visit www.christianrecord.org.